TY  - JOUR
AU  - Coghill, David R
AU  - Banaschewski, Tobias
AU  - Nagy, Peter
AU  - Otero, Isabel Hernández
AU  - Soutullo, César
AU  - Yan, Brian
AU  - Caballero, Beatriz
AU  - Zuddas, Alessandro
PY  - 2017
DO  - 10.1007/s40263-017-0443-y
UR  - http://hdl.handle.net/10668/11364
T2  - CNS drugs
AB  - Attention-deficit/hyperactivity disorder (ADHD) is increasingly recognized as a persistent disorder requiring long-term management. Our objective was to evaluate the 2-year safety and efficacy of lisdexamfetamine dimesylate (LDX) in children and...
LA  - en
KW  - Adolescent
KW  - Attention Deficit Disorder with Hyperactivity
KW  - Body Weight
KW  - Central Nervous System Stimulants
KW  - Child
KW  - Electrocardiography
KW  - Europe
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lisdexamfetamine Dimesylate
KW  - Male
KW  - Psychiatric Status Rating Scales
KW  - Time Factors
KW  - Treatment Outcome
TI  - Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe.
TY  - research article
VL  - 31
ER  -